Clinical Trial Update: A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant FOLFOX6 with short-course radiotherapy for unresectable rectal cancer with liver metastasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Yonsei University | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED